Stocks are narrowly mixed on Friday, putting the S&P 500 and Nasdaq at risk of snapping a six-day winning streak.
Jim Cramer focuses on Blackberry, Exact Sciences, Splunk, Freeport-McMoRan and more.
Jim Cramer says it's more than just the cloud. There are some astounding moves in the broader tech sector, too.
AstraZeneca shares edged higher Tuesday as investors shrugged off a mixed set of phase-3 results for the Anglo Swedish drug maker's Bydureon Exscel type II diabetes treatment.